lncRNA DLX6-AS1在恶性肿瘤中的研究进展
Research Progress of lncRNA DLX6-AS1 in Malignant Tumors
DOI: 10.12677/WJCR.2023.132007, PDF,    科研立项经费支持
作者: 桂宇欣, 孙杰克, 石玉荣*：蚌埠医学院检验医学院，安徽 蚌埠
关键词: 长链非编码RNAs；DLX6-AS1；恶性肿瘤；研究进展；Long-Chain Non-Coding RNAs； DLX6-AS1； Malignant Tumor； Research Progress
摘要: 长链非编码RNAs表达具备时间特异性和空间特异性。DLX6-AS1是lncRNAs家族中的一员，其表达水平在多种恶性肿瘤中发生显著改变，提示DLX6-AS1在肿瘤的发生、发展和预后中发挥作用。文章对近５年国内外关于DLX6-AS1在恶性肿瘤中的研究进行综述，以期为恶性肿瘤的诊断和潜在治疗靶点选择提供参考。
Abstract: The expression of long-chain noncoding RNAs is time-specific and space-specific. DLX6-AS1 is a member of the lncRNAs family, and its expression level has changed significantly in a variety of malignant tumors, suggesting that DLX6-AS1 plays a role in the occurrence, development and prognosis of tumors. This article reviews the research on DLX6-AS1 in malignant tumors at home and abroad in the past five years, in order to provide reference for the diagnosis of malignant tumors and the selection of potential therapeutic targets.
文章引用：桂宇欣, 孙杰克, 石玉荣. lncRNA DLX6-AS1在恶性肿瘤中的研究进展[J]. 世界肿瘤研究, 2023, 13(2): 44-50. https://doi.org/10.12677/WJCR.2023.132007

参考文献

[1] Chi, Y., Wang, D., Wang, J., et al. (2019) Long Non-Coding RNA in the Pathogenesis of Cancers. Cells, 8, 1015.
[Google Scholar] [CrossRef] [PubMed]
[2] Sun, W., Zhang, L., Yan, R., et al. (2019) LncRNA DLX6-AS1 Promotes the Proliferation, Invasion, and Migration of Non-Small Cell Lung Cancer Cells by Targeting the miR-27b-3p/GSPT1 Axis. OncoTargets and Therapy, 12, 3945-3954.
[Google Scholar] [CrossRef] 
[3] Zhang, X., Guo, H., Bao, Y., et al. (2019) Exosomal Long Non-Coding RNA DLX6-AS1 as a Potential Diagnostic Biomarker for Non-Small Cell Lung Cancer. Oncology Letters, 18, 5197-5204.
[Google Scholar] [CrossRef] [PubMed]
[4] Fu, X., Tian, Y., Kuang, W., et al. (2019) Long Non-Coding RNA DLX6-AS1 Silencing Inhibits Malignant Phenotypes of Gastric Cancer Cells. Experimental and Therapeutic Medicine, 17, 4715-4722.
[Google Scholar] [CrossRef] [PubMed]
[5] Zhang, L., He, X., Jin, T., et al. (2017) Long Non-Coding RNA DLX6-AS1 Aggravates Hepatocellular Carcinoma Carcinogenesis by Modulating miR-203a/MMP-2 Pathway. Biomedicine & Pharmacotherapy, 96, 884-891.
[Google Scholar] [CrossRef] [PubMed]
[6] Hosseini, N.F., Manoochehri, H., Khoei, S.G., et al. (2021) The Functional Role of Long Non-Coding RNA UCA1 in Human Multiple Cancers: A Review Study. Current Molecular Medicine, 21, 96-110.
[Google Scholar] [CrossRef] [PubMed]
[7] Ginn, L., Shi, L., Montagna, M., et al. (2020) LncRNAs in Non-Small-Cell Lung Cancer. Noncoding RNA, 6, 25.
[Google Scholar] [CrossRef] [PubMed]
[8] Schmitt Adam, M., et al. (2016) An Inducible Long Noncoding RNA Amplifies DNA Damage Signaling. Nature Genetics, 48, 1370-1376.
[Google Scholar] [CrossRef] [PubMed]
[9] Zhang, L., Ge, S. and Cao, B. (2020) Long Non-Coding RNA MIAT Promotes Cervical Cancer Proliferation and Migration. The Journal of Biochemistry, 168, 183-190.
[Google Scholar] [CrossRef] [PubMed]
[10] Zhou, J.L., Zou, L. and Zhu, T. (2020) Long Non-Coding RNA LINC00665 Promotes Metastasis of Breast Cancer Cells by Triggering EMT. European Review for Medical and Pharmacological Sciences, 24, 3097-3104.
[11] Zhu, Z., Wang, H., Pang, Y., et al. (2020) Exosomal Long Non-Coding RNA UCA1 Functions as Growth Inhibitor in Esophageal Cancer. Aging (Albany NY), 12, 20523-20539.
[Google Scholar] [CrossRef] [PubMed]
[12] Zhou, Y., Zhao, Y., Li, Q., et al. (2020) Long Non-Coding RNA TUSC8 Inhibits Breast Cancer Growth and Metastasis via miR-190b-5p/MYLIP Axis. Aging (Albany NY), 12, 2974-2991.
[Google Scholar] [CrossRef] [PubMed]
[13] Huang, Y., Ni, R., Wang, J., et al. (2019) Knockdown of lncRNA DLX6-AS1 Inhibits Cell Proliferation, Migration and Invasion while Promotes Apoptosis by Downregulating PRR11 Expression and Upregulating miR-144 in Non-Small Cell Lung Cancer. Biomedicine & Pharmacotherapy, 109, 1851-1859.
[Google Scholar] [CrossRef] [PubMed]
[14] Wu, C., Lin, W. and Fu, F. (2021) Long Non-Coding RNA DLX6-AS1 Knockdown Suppresses the Tumorigenesis and Progression of Non-Small Cell Lung Cancer through microRNA-16-5p/BMI1 Axis. Translational Cancer Research, 10, 3772-3787.
[Google Scholar] [CrossRef] [PubMed]
[15] Zhao, X., Wang, J., Zhu, R., et al. (2021) DLX6-AS1 Activated by H3K4me1 Enhanced Secondary Cisplatin Resistance of Lung Squamous Cell Carcinoma through Modulating miR-181a-5p/miR-382-5p/CELF1 Axis. Scientific Reports, 11, Article No. 21014.
[Google Scholar] [CrossRef] [PubMed]
[16] Wu, Q., Ma, J., Meng, W., et al. (2020) DLX6-AS1 Promotes Cell Proliferation, Migration and EMT of Gastric Cancer through FUS-Regulated MAP4K1. Cancer Biology & Therapy, 21, 17-25.
[Google Scholar] [CrossRef] [PubMed]
[17] Qian, Y., Song, W., Wu, X., et al. (2021) DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290. Digestive Diseases and Sciences, 66, 460-473.
[Google Scholar] [CrossRef] [PubMed]
[18] Li, D., Tang, X., Li, M., et al. (2019) Long Noncoding RNA DLX6-AS1 Promotes Liver Cancer by Increasing the Expression of WEE1 via Targeting miR-424-5p. Journal of Cellular Biochemistry, 120, 12290-12299.
[Google Scholar] [CrossRef] [PubMed]
[19] Liu, X., Peng, D., Cao, Y., et al. (2021) Upregulated lncRNA DLX6-AS1 Underpins Hepatocellular Carcinoma Progression via the miR-513c/Cul4A/ANXA10 Axis. Cancer Gene Therapy, 28, 486-501.
[Google Scholar] [CrossRef] [PubMed]
[20] An, Y., Chen, X.M., Yang, Y., et al. (2018) LncRNA DLX6-AS1 Promoted Cancer Cell Proliferation and Invasion by Attenuating the Endogenous Function of miR-181b in Pancreatic Cancer. Cancer Cell International, 18, Article No. 143.
[Google Scholar] [CrossRef] [PubMed]
[21] Yang, J., Ye, Z., Mei, D., et al. (2019) Long Noncoding RNA DLX6-AS1 Promotes Tumorigenesis by Modulating miR-497-5p/FZD4/FZD6/Wnt/β-Catenin Pathway in Pancreatic Cancer. Cancer Management and Research, 11, 4209-4221.
[Google Scholar] [CrossRef] 
[22] Zhang, J.J., Xu, W.R., Chen, B., et al. (2019) The Up-Regulated lncRNA DLX6-AS1 in Colorectal Cancer Promotes Cell Proliferation, Invasion and Migration via Modulating PI3K/AKT/mTOR Pathway. European Review for Medical and Pharmacological Sciences, 23, 8321-8331.
[23] Kong, W.Q., Liang, J.J., Du, J., et al. (2021) Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells via Mediating the miR-26a/EZH2 Axis. Cancer Biotherapy and Radiopharmaceuticals, 36, 753-764.
[Google Scholar] [CrossRef] [PubMed]
[24] Guo, J., Chen, Z., Jiang, H., et al. (2019) The lncRNA DLX6-AS1 Promoted Cell Proliferation, Invasion, Migration and Epithelial-to-Mesenchymal Transition in Bladder Cancer via Modulating Wnt/β-Catenin Signaling Pathway. Cancer Cell International, 19, Article No. 312.
[Google Scholar] [CrossRef] [PubMed]
[25] Wang, H., Niu, X., Jiang, H., et al. (2020) Long Non-Coding RNA DLX6-AS1 Facilitates Bladder Cancer Progression through Modulating miR-195-5p/VEGFA Signaling Pathway. Aging (Albany NY), 12, 16021-16034.
[Google Scholar] [CrossRef] [PubMed]
[26] Fang, C., Xu, L., He, W., et al. (2019) Long Noncoding RNA DLX6-AS1 Promotes Cell Growth and Invasiveness in Bladder Cancer via Modulating the miR-223-HSP90B1 Axis. Cell Cycle, 18, 3288-3299.
[Google Scholar] [CrossRef] [PubMed]
[27] Ding, X.Z., Zhang, S.Q., Deng, X.L., et al. (2021) Serum Exosomal lncRNA DLX6-AS1 Is a Promising Biomarker for Prognosis Prediction of Cervical Cancer. Technology in Cancer Research & Treatment, 20.
[Google Scholar] [CrossRef] [PubMed]
[28] Xie, F., Xie, G. and Sun, Q. (2020) Long Noncoding RNA DLX6-AS1 Promotes the Progression in Cervical Cancer by Targeting miR-16-5p/ARPP19 Axis. Cancer Biotherapy and Radiopharmaceuticals, 35, 129-136.
[Google Scholar] [CrossRef] [PubMed]
[29] Wang, X., Lin, Y. and Liu, J. (2019) Long Non-Coding RNA DLX6-AS1 Promotes Proliferation by Acting as a ceRNA Targeting miR-199a in Cervical Cancer. Molecular Medicine Reports, 19, 1248-1255.
[Google Scholar] [CrossRef] [PubMed]
[30] Zhao, H. and Xu, Q. (2020) Long Non-Coding RNA DLX6-AS1 Mediates Proliferation, Invasion and Apoptosis of Endometrial Cancer Cells by Recruiting p300/E2F1 in DLX6 Promoter Region. Journal of Cellular and Molecular Medicine, 24, 12572-12584.
[Google Scholar] [CrossRef] [PubMed]
[31] Zhao, J. and Liu, H.R. (2019) Down-Regulation of Long Noncoding RNA DLX6-AS1 Defines Good Prognosis and Inhibits Proliferation and Metastasis in Human Epithelial Ovarian Cancer Cells via Notch Signaling Pathway. European Review for Medical and Pharmacological Sciences, 23, 3243-3252.
[32] Zhu, X., Ma, X., Zhao, S., et al. (2021) DLX6-AS1 Accelerates Cell Proliferation through Regulating miR-497-5p/SNCG Pathway in Prostate Cancer. Environmental Toxicology, 36, 308-319.
[Google Scholar] [CrossRef] [PubMed]
[33] Zhao, P., Guan, H., Dai, Z., et al. (2019) Long Noncoding RNA DLX6-AS1 Promotes Breast Cancer Progression via miR-505-3p/RUNX2 Axis. European Journal of Pharmacology, 2865, Article ID: 172778.
[Google Scholar] [CrossRef] [PubMed]
[34] Du, C., Wang, Y., Zhang, Y., et al. (2020) LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-Negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis. Cell Transplantation, 29.
[Google Scholar] [CrossRef] [PubMed]
[35] Liu, Y., Liu, X., Zhang, X., et al. (2020) lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway. Cancer Management and Research, 12, 2685-2695.
[Google Scholar] [CrossRef] 
[36] Yang, Q., Sun, J., Ma, Y., et al. (2019) LncRNA DLX6-AS1 Promotes Laryngeal Squamous Cell Carcinoma Growth and Invasion through Regulating miR-376c. American Journal of Translational Research, 11, 7009-7017.

为你推荐